Why the study?
The reliability of mesenteric fat assessment by intestinal ultrasound and its correlation with disease activity biomarkers in children with Crohn's disease were unknown.
Does the Chicago Mesenteric Fat Index provide reliable assessment of mesenteric fat and correlate with disease activity in pediatric Crohn's disease?
Does the Chicago Mesenteric Fat Index provide reliable assessment of mesenteric fat and correlate with disease activity in pediatric Crohn's disease?
The Chicago Mesenteric Fat Index is a reliable and reproducible sonographic tool that correlates with disease activity indicators in pediatric Crohn's disease.
CMFI shows promise as a reliable sonographic marker in pediatric Crohn's; hypothesis-generating and should not yet change practice.
BACKGROUND: Intestinal ultrasound (IUS) provides a noninvasive means of assessing Crohn's disease (CD), including visualization of mesenteric fat (MF) wrapping. Reliability of MF assessment and correlation with disease activity biomarkers in children is unknown. This study assessed the interrater reliability (IRR) of a binary assessment and a novel semi-quantitative index for grading MF wrapping using IUS (Chicago Mesenteric Fat Index [CMFI]) and correlation with disease activity biomarkers in pediatric patients with CD. METHODS: Children (≤18 years of age) with ileal CD who underwent IUS at 2 centers were enrolled. Three expert sonographers independently graded MF as present/absent and by the CMFI. IRR was calculated using Fleiss' kappa coefficient. Correlations between MF and clinical characteristics, inflammatory markers, and IUS data were calculated. RESULTS: Eighty IUS exams in 67 patients were included. The IRR was substantial for binary MF (κ = 0.744) and CMFI (κ = 0.618). Increasing CMFI grade was associated with bowel wall thickness (P < .001; odds ratio [OR], 16.35; 95% confidence interval [CI], 5.74-46.58), presence of ileal stricture (P < .001; OR, 30.32; 95% CI, 5.74-160.15), and presence of hyperemia (P = .001; OR, 6.59; 95% CI, 2.27-19.09). CONCLUSION: Assessment of MF on IUS is reproducible and reliable in pediatric CD. The CMFI can be used as a biomarker that mirrors biochemical and sonographic indicators of pediatric CD activity.
No takes yet. Share an insight, caveat, or question.
Kellar et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: